Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
ConditionSpinal Fusion
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
AgeUp to 26
SponsorAkron Children's Hospital
About this trial
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
Eligibility criteria
Qualifiers
Males and females
Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine
English Speaking
Disqualifiers
Patients who have undergone prior spinal surgery
Undergoing procedures other than primary posterior spinal fusion of the thoracic and/or lumbar spine (cervical fusion, anterior surgery, growth-friendly instrumentation)
Any contraindication to povidone-iodine, including pregnancy, allergy, or prior treatment with radioiodine
Trial design
Treatments tested in this trial
- 10% Povidone-Iodine Arm
- Saline Arm
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov